Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 7R21AG061471-02 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute on Aging (NIA) | NIH |
| The University of Texas at Arlington | OTHER |
Not provided
Not provided
Not provided
The project is designed to develop and test Pressure Alternating Shoes (PAS), which will periodically off-load certain regions of the foot in order to prevent foot ulcers. An automated dual layer insole compromised of an active pressurized actuator array in combination with a passive compliant layer on top of each actuator to modulate and distribute the plantar surface pressure as desired will be tested. This device will allow us to simultaneously load and offload select areas of the foot using the active layer by inflating and deflating individual actuators using pressurized air. After offloading, the remaining load will be distributed to other areas with inflated actuators. Automatic modulation will be provided through programmable control hardware which will cyclically relieve mechanical loading based on a prescribed duration and frequency.
The two-tier human subjects study will be conducted to assess the biomechanical characteristics of PAS. In the first tier, we will test PAS in healthy subjects and in the second tier, we will test PAS in Diabetic Neuropathy patients (DN).
Subjects will walk on a treadmill in their usual daily shoes for 5 minutes, then with standard diabetic shoes with the PAS insoles for 5 minutes. Subjects will wear body worn sensors that assess position of the body. Subjects will have the temperature of their feet measured via a special camera after walking. Subjects will rest for 30 minute washout period and have the blood flow in the soles of the feet measured via a special camera. 1 healthy subject will undergo MRI of the foot and ankle.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Healthy controls | Experimental | Patients without diabetes who do not have foot wounds or history of amputation |
|
| Patients with Diabetic Neuropathy | Experimental | Patients with diagnosed diabetes and neuropathy who do not have foot wounds or history of amputation. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| test pressure alternating shoes | Device | test pressure alternating shoes |
|
| Measure | Description | Time Frame |
|---|---|---|
| Maximum Average Pressure at Baseline With Pressure Alternating Shoes, Right Foot (Before Any Cells Were Offloaded) | Maximum Average pressure values in the plantar regions before offloading during walking. The insole consists of seven air cells that align with specific regions: the big toe (cell 1), the area spanning from the second toe to the fifth toe (cell 2), metatarsal heads (cells 3 and 4), the midfoot (cells 5 and 6), and the heel (cell 7). Measurements were only obtained from the right foot. | Before any cells were offloaded (First 40-seconds of the walk) |
| Maximum Average Pressure at After Offloading - Diabetic Footwear Equipped With PAS Device | Maximum Average pressure values in the plantar regions after offloading cells during walking. The insole consists of seven air cells that align with specific regions: the big toe (cell 1), the area spanning from the second toe to the fifth toe (cell 2), metatarsal heads (cells 3 and 4), the midfoot (cells 5 and 6), and the heel (cell 7). Measurements were only obtained from the right foot. The results reported represent results for footwear with PAS device. | After offloading (approx. 41- 200 seconds walk) |
| Peak Interface Pressure at Baseline (Before Offloading) - Diabetic Footwear Equipped With PAS Device | Peak Interface Pressure values in the plantar regions before offloading during walking. The insole consists of seven air cells that align with specific regions: the big toe (cell 1), the area spanning from the second toe to the fifth toe (cell 2), metatarsal heads (cells 3 and 4), the midfoot (cells 5 and 6), and the heel (cell 7). Measurements were only obtained from the right foot. The results reported represent results for footwear with PAS device. | Baseline (First 40-seconds of the walk) |
| Peak Interface Pressure at After Offloading - Diabetic Footwear Equipped With PAS Device | Peak Interface Pressure values in the plantar regions after offloading during walking. The insole consists of seven air cells that align with specific regions: the big toe (cell 1), the area spanning from the second toe to the fifth toe (cell 2), metatarsal heads (cells 3 and 4), the midfoot (cells 5 and 6), and the heel (cell 7). Measurements were only obtained from the right foot. The results reported represent results for footwear with PAS device. |
| Measure | Description | Time Frame |
|---|---|---|
| Plantar Skin Temperature at Baseline, Right Foot | Plantar skin temperature measured by a noncontact thermal imaging camera (*Celcius) before the intervention and without footwear | Baseline before the intervention (30 minutes after start of visit 1) |
| Plantar Skin Temperature Post Intervention, Right Foot |
Not provided
Healthy Controls:
Inclusion Criteria:
Exclusion Criteria:
Diabetic population:
Inclusion:
Excluision:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Peter Crisologo, D.P.M. | University of Texas Southwestern Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390-8560 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Due to design & device constraints, unable to randomize between left/right foot (PAS device) between subjects & were asked to walk with daily shoes on treadmill-5 mins (Control data). Order of sessions (PAS & Daily footwear) weren't randomized as in crossover study. After testing PAS device, daily footwear use data was collected in healthy subjects (Tier 1). Study procedures (use of PAS and daily footwear) in Tier 2- diabetic neuropathic subjects followed the same sequence as in Tier 1.
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Healthy Controls (Tier 1) | Patients without diabetes who do not have foot wounds or history of amputation. Pressure alternating shoe insoles were placed in both the right and left post-operative shoes. Both insoles were inflated to the same pressure to prevent uneven foot elevation and promote stabilization. However, only the right-side insole was connected to the control box to inflate and offload air cells during the test. Due to design and device constraints, we were unable to randomize between the left or right foot between subjects. Although the protocol mentions diabetic footwear, this is a broad phrase that encompasses post operative shoes as there are many real-world patients who use post operative shoes as their footwear. Subjects were then asked to walk with their daily shoes on the treadmill for 5 minutes (Control data). The order of these sessions / sequence (PAS and Daily footwear) were not randomized as in a cross-over study. After testing PAS device, daily footwear (control data) was collected in health subjects (Tier 1). No amendment to the protocol was made for the change in study flow. This was a minor deviation, and we have completed a deviation form for the same and filed it within the study binder. |
| FG001 | Patients With Diabetic Neuropathy (Tier 2) | Patients with diagnosed diabetes and neuropathy with superficial ulcers and/or history of surgery/partial amputation. Pressure alternating shoe insoles were placed in both the right and left post-operative shoes. Both insoles were inflated to the same pressure to prevent uneven foot elevation and promote stabilization. However, only the right-side insole was connected to the control box to inflate and offload air cells during the test (5 mins). Due to design and device constraints, we were unable to randomize between the left or right foot between subjects. Subjects were then asked to walk with their daily shoes on the treadmill for 5 minutes (Control data). The order of these sessions / sequence (PAS and Daily footwear) were not randomized as in a cross-over study. After testing PAS device, daily footwear (control data) was collected in diabetic neuropathic subjects (Tier 2). No amendment to the protocol was made for the change in study flow. This was a minor deviation, and we have completed a deviation form for the same and filed it within the study binder. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Session 1- Tier 1 Subjects(5 Mins) |
| |||||||||||||
| Session 2-Tier 2 Subjects(5 Mins) |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Healthy Controls- Tier 1 | Pressure alternating shoe insoles were placed in both the right and left post-operative shoes. Both insoles were inflated to the same pressure to prevent uneven foot elevation and promote stabilization. However, only the right-side insole was connected to the control box to inflate and offload air cells during the test. Due to design and device constraints, we were unable to randomize between the left or right foot between subjects. Although the protocol mentions diabetic footwear, this is a broad phrase that encompasses post operative shoes as there are many real-world patients who use post operative shoes as their footwear. Subjects were then asked to walk with their daily shoes on the treadmill for 5 minutes (Control data). The order of these sessions / sequence (PAS and Daily footwear) were not randomized as in a cross-over study. After testing PAS device, daily footwear (control data) was collected in health subjects (Tier 1). No amendment to the protocol was made for the change in study flow. This was a minor deviation, and we have completed a deviation form for the same and filed it within the study binder. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Maximum Average Pressure at Baseline With Pressure Alternating Shoes, Right Foot (Before Any Cells Were Offloaded) | Maximum Average pressure values in the plantar regions before offloading during walking. The insole consists of seven air cells that align with specific regions: the big toe (cell 1), the area spanning from the second toe to the fifth toe (cell 2), metatarsal heads (cells 3 and 4), the midfoot (cells 5 and 6), and the heel (cell 7). Measurements were only obtained from the right foot. | Due to technical issues like unexpected stop in the interface pressure data collection during testing and insole control box not functioning properly, resulted in incomplete data collection for 4 healthy subjects and therefore not included in the analysis of this outcome measure. All successfully collected data are reported. | Posted | Mean | Standard Deviation | kPa | Before any cells were offloaded (First 40-seconds of the walk) |
|
approximately 2 hours
The arms are represented in this fashion to show there were no adverse events between patients with and without diabetic neuropathy as they both received the intervention.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Healthy Controls | Patients without diabetes who do not have foot wounds or history of amputation |
Not provided
Not provided
Ex-PI left institution after enrollment completion in study. Data not collected for 'Balance' outcome due to technical issues involving body worn sensor connectivity. For remaining, outcomes due to technical issues like unexpected stop in interface pressure data collection during testing & insole control box not functioning properly, it resulted in inability to collect pressure data for 4 healthy subjects & so not included in analysis.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr. Peter Crisologo | UT Southwestern Medical Center | 214/648-7284 | Peter.Crisologo@UTSouthwestern.edu |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Nov 10, 2024 | Apr 29, 2025 | Prot_SAP_001.pdf |
| ICF | No | No | Yes | Informed Consent Form | Jun 12, 2024 | Sep 25, 2024 | ICF_000.pdf |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D017719 | Diabetic Foot |
| ID | Term |
|---|---|
| D003925 | Diabetic Angiopathies |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D016523 | Foot Ulcer |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| After offloading (approx. 41- 200 seconds walk) |
| Max Average Pressure Change Among All Participants - Diabetic Footwear Equipped With PAS Device | Percentage change due to offloading for each participant is measured by dividing the pressure difference between the after offloading and before offloading values divided by the before offloading value. Measurements were only obtained from the right foot. The results reported represent results for footwear with PAS device. | Baseline (first 40-second walk), 201 seconds after the intervention ended |
| Peak Pressure Change Among All Participants - Diabetic Footwear Equipped With PAS Device | Peak pressure change due to offloading for each participant is measured by dividing the pressure difference between the peak after offloading and peak before offloading values divided by the peak before offloading value. Measurements were only obtained from the right foot. The results reported represent results for footwear with PAS device. | Baseline (first 40-second walk), 201 seconds after the intervention ended |
Plantar skin temperature measured by a noncontact thermal imaging camera (*Celcius) post intervention, without footwear |
| Post intervention (215 seconds) |
| Tissue Oxygenation (Oxygen Saturation) - for Plantar Lateral Foot | Plantar foot tissue oxygenation (Oxygen saturation) is measured by noncontact hyperspectral imaging camera (StO2). Only the right foot was analyzed and without footwear. | Baseline (30 minutes after start of visit 1) |
| Tissue Oxygenation (Oxyhemoglobin and Deoxyhemoglobin ) - for Plantar Lateral Foot | Plantar foot tissue oxygenation (Oxyhemoglobin and Deoxyhemoglobin) is measured by noncontact hyperspectral imaging (HSI) camera. Only the right foot was analyzed and without footwear. The accepted measure of oxyhemoglobin and deoxyhemoglobin is arbitrary units (AU). NIR spectrum light passes through skin and is reflected off the blood supplying the tissue. Wavelength dependent light absorption of hemoglobin differs if it is carrying oxygen or not, therefore detecting oxygenated and deoxygenated blood. This was derived from Beer-Lambert Law but would need to be verified by the manufacturer. There is no researcher drawn calculation as the device provides the arbitrary unit based on the reflectance detected back to the imaging device. No reference values or any standardization available but one would infer higher oxyhemoglobin level indicates better oxygenation and thus a higher deoxyhemoglobin would be indicative of poor oxygenation. | Baseline (30 minutes after start of visit 1) |
| Tissue Oxygenation (Oxygen Saturation) - for Plantar Medial Foot | Plantar Medial foot tissue oxygenation (Oxygen saturation) is measured by noncontact hyperspectral imaging camera (StO2). Only the right foot was analyzed and without footwear. | Baseline (30 minutes after start of visit 1) |
| Tissue Oxygenation (Oxyhemoglobin and Deoxyhemoglobin) - for Plantar Medial Foot | Plantar medial foot tissue oxygenation (Oxyhemoglobin and Deoxyhemoglobin) is measured by noncontact hyperspectral imaging (HSI) camera. Only the right foot was analyzed. Only the right foot was analyzed and without footwear. The accepted measure of oxyhemoglobin and deoxyhemoglobin is arbitrary units (AU). NIR spectrum light passes through skin and is reflected off the blood supplying the tissue. Wavelength dependent light absorption of hemoglobin differs if it is carrying oxygen or not, therefore detecting oxygenated and deoxygenated blood. This was derived from Beer-Lambert Law but would need to be verified by the manufacturer. There is no researcher drawn calculation as the device provides the arbitrary unit based on the reflectance detected back to the imaging device. No reference values or any standardization available but one would infer higher oxyhemoglobin level indicates better oxygenation and thus a higher deoxyhemoglobin would be indicative of poor oxygenation. | Baseline (30 minutes after start of visit 1) |
| Tissue Oxygenation (Oxygen Saturation) - for Plantar Lateral Foot | Plantar foot tissue oxygenation (Oxygen saturation) is measured by noncontact hyperspectral imaging camera (StO2). Only the right foot was analyzed and without footwear. | Post Gait (approx. 2015 seconds post intervention) |
| Tissue Oxygenation (Oxyhemoglobin and Deoxyhemoglobin ) - for Plantar Lateral Foot | Plantar foot tissue oxygenation (Oxyhemoglobin and Deoxyhemoglobin) is measured by noncontact hyperspectral imaging (HSI) camera. Only the right foot was analyzed and without footwear. The accepted measure of oxyhemoglobin and deoxyhemoglobin is arbitrary units (AU). NIR spectrum light passes through skin and is reflected off the blood supplying the tissue. Wavelength dependent light absorption of hemoglobin differs if it is carrying oxygen or not, therefore detecting oxygenated and deoxygenated blood. This was derived from Beer-Lambert Law but would need to be verified by the manufacturer. There is no researcher drawn calculation as the device provides the arbitrary unit based on the reflectance detected back to the imaging device. No reference values or any standardization available but one would infer higher oxyhemoglobin level indicates better oxygenation and thus a higher deoxyhemoglobin would be indicative of poor oxygenation. | Post Gait (approx. 2015 seconds post intervention) |
| Tissue Oxygenation (Oxygen Saturation) - for Plantar Medial Foot | Plantar Medial foot tissue oxygenation (Oxygen saturation) is measured by noncontact hyperspectral imaging camera (StO2). Only the right foot was analyzed and without footwear. | Post Gait (approx. 2015 seconds post intervention) |
| Tissue Oxygenation (Oxyhemoglobin and Deoxyhemoglobin) - for Plantar Medial Foot | Plantar medial foot tissue oxygenation (Oxyhemoglobin and Deoxyhemoglobin) is measured by noncontact hyperspectral imaging (HSI) camera. Only the right foot was analyzed and without footwear. The accepted measure of oxyhemoglobin and deoxyhemoglobin is arbitrary units (AU). NIR spectrum light passes through skin and is reflected off the blood supplying the tissue. Wavelength dependent light absorption of hemoglobin differs if it is carrying oxygen or not, therefore detecting oxygenated and deoxygenated blood. This was derived from Beer-Lambert Law but would need to be verified by the manufacturer. There is no researcher drawn calculation as the device provides the arbitrary unit based on the reflectance detected back to the imaging device. No reference values or any standardization available but one would infer higher oxyhemoglobin level indicates better oxygenation and thus a higher deoxyhemoglobin would be indicative of poor oxygenation. | Post Gait (approx. 2015 seconds post intervention) |
| Balance | Positional sense measured by body-worn sensors (cm) | Baseline |
| NOT COMPLETED |
|
| BG001 | Patients With Diabetic Neuropathy- Tier 2 | Patients with diagnosed diabetes and neuropathy with superficial ulcers and/or history of surgery/partial amputation. Pressure alternating shoe insoles were placed in both the right and left post-operative shoes. Both insoles were inflated to the same pressure to prevent uneven foot elevation and promote stabilization. However, only the right-side insole was connected to the control box to inflate and offload air cells during the test (5 mins). Due to design and device constraints, we were unable to randomize between the left or right foot between subjects. Subjects were then asked to walk with their daily shoes on the treadmill for 5 minutes (Control data). The order of these sessions / sequence (PAS and Daily footwear) were not randomized as in a cross-over study. After testing PAS device, daily footwear (control data) was collected in diabetic neuropathic subjects (Tier 2). No amendment to the protocol was made for the change in study flow. This was a minor deviation, and we have completed a deviation form for the same and filed it within the study binder. |
| BG002 | Total | Total of all reporting groups |
| Participants |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
|
| Race/Ethnicity, Customized | Count of Participants | Participants |
|
Patients without diabetes who do not have foot wounds or history of amputation |
| OG001 | Patients With Diabetic Neuropathy | Patients with diagnosed diabetes and neuropathy who do not have foot wounds or history of amputation. |
|
|
| Primary | Maximum Average Pressure at After Offloading - Diabetic Footwear Equipped With PAS Device | Maximum Average pressure values in the plantar regions after offloading cells during walking. The insole consists of seven air cells that align with specific regions: the big toe (cell 1), the area spanning from the second toe to the fifth toe (cell 2), metatarsal heads (cells 3 and 4), the midfoot (cells 5 and 6), and the heel (cell 7). Measurements were only obtained from the right foot. The results reported represent results for footwear with PAS device. | Due to technical issues like unexpected stop in the interface pressure data collection during testing and insole control box not functioning properly, resulted in incomplete data collection for 4 healthy subjects and therefore not included in the analysis of this outcome measure. All successfully collected data are reported. This outcome was only assessed for subjects (in both Tiers) with Diabetic Footwear Equipped With PAS Device. | Posted | Mean | Standard Deviation | kPa | After offloading (approx. 41- 200 seconds walk) |
|
|
|
| Primary | Peak Interface Pressure at Baseline (Before Offloading) - Diabetic Footwear Equipped With PAS Device | Peak Interface Pressure values in the plantar regions before offloading during walking. The insole consists of seven air cells that align with specific regions: the big toe (cell 1), the area spanning from the second toe to the fifth toe (cell 2), metatarsal heads (cells 3 and 4), the midfoot (cells 5 and 6), and the heel (cell 7). Measurements were only obtained from the right foot. The results reported represent results for footwear with PAS device. | Due to technical issues like unexpected stop in the interface pressure data collection during testing and insole control box not functioning properly, resulted in incomplete data collection for 4 healthy subjects and therefore not included in the analysis of this outcome measure. All successfully collected data are reported. This outcome was only assessed for subjects (in both Tiers) with Diabetic Footwear Equipped With PAS Device. | Posted | Mean | Standard Deviation | kPa | Baseline (First 40-seconds of the walk) |
|
|
|
| Primary | Peak Interface Pressure at After Offloading - Diabetic Footwear Equipped With PAS Device | Peak Interface Pressure values in the plantar regions after offloading during walking. The insole consists of seven air cells that align with specific regions: the big toe (cell 1), the area spanning from the second toe to the fifth toe (cell 2), metatarsal heads (cells 3 and 4), the midfoot (cells 5 and 6), and the heel (cell 7). Measurements were only obtained from the right foot. The results reported represent results for footwear with PAS device. | Due to technical issues like unexpected stop in the interface pressure data collection during testing and insole control box not functioning properly, resulted in incomplete data collection for 4 healthy subjects and therefore not included in the analysis of this outcome measure. All successfully collected data are reported. This outcome was only assessed for subjects (in both Tiers) with Diabetic Footwear Equipped With PAS Device. | Posted | Mean | Standard Deviation | kPa | After offloading (approx. 41- 200 seconds walk) |
|
|
|
| Primary | Max Average Pressure Change Among All Participants - Diabetic Footwear Equipped With PAS Device | Percentage change due to offloading for each participant is measured by dividing the pressure difference between the after offloading and before offloading values divided by the before offloading value. Measurements were only obtained from the right foot. The results reported represent results for footwear with PAS device. | Due to technical issues like unexpected stop in the interface pressure data collection during testing and insole control box not functioning properly, resulted in incomplete data collection for 4 healthy subjects and therefore not included in the analysis of this outcome measure. All successfully collected data are reported. This outcome was only assessed for subjects (in both Tiers) with Diabetic Footwear Equipped With PAS Device. | Posted | Mean | Standard Deviation | percent change | Baseline (first 40-second walk), 201 seconds after the intervention ended |
|
|
|
| Primary | Peak Pressure Change Among All Participants - Diabetic Footwear Equipped With PAS Device | Peak pressure change due to offloading for each participant is measured by dividing the pressure difference between the peak after offloading and peak before offloading values divided by the peak before offloading value. Measurements were only obtained from the right foot. The results reported represent results for footwear with PAS device. | Due to technical issues like unexpected stop in the interface pressure data collection during testing and insole control box not functioning properly, resulted in incomplete data collection for 4 healthy subjects and therefore not included in the analysis of this outcome measure. All successfully collected data are reported. This outcome was only assessed for subjects (in both Tiers) with Diabetic Footwear Equipped With PAS Device. | Posted | Mean | Standard Deviation | percent change | Baseline (first 40-second walk), 201 seconds after the intervention ended |
|
|
|
| Secondary | Plantar Skin Temperature at Baseline, Right Foot | Plantar skin temperature measured by a noncontact thermal imaging camera (*Celcius) before the intervention and without footwear | Posted | Mean | Standard Deviation | degree Celsius | Baseline before the intervention (30 minutes after start of visit 1) |
|
|
|
| Secondary | Plantar Skin Temperature Post Intervention, Right Foot | Plantar skin temperature measured by a noncontact thermal imaging camera (*Celcius) post intervention, without footwear | Posted | Mean | Standard Deviation | degree Celsius | Post intervention (215 seconds) |
|
|
|
| Secondary | Tissue Oxygenation (Oxygen Saturation) - for Plantar Lateral Foot | Plantar foot tissue oxygenation (Oxygen saturation) is measured by noncontact hyperspectral imaging camera (StO2). Only the right foot was analyzed and without footwear. | We gathered and assessed measurements of the plantar lateral foot at baseline for both healthy and diabetic participants combined that is reported here. | Posted | Median | Inter-Quartile Range | percentage StO2 | Baseline (30 minutes after start of visit 1) |
|
|
|
| Secondary | Tissue Oxygenation (Oxyhemoglobin and Deoxyhemoglobin ) - for Plantar Lateral Foot | Plantar foot tissue oxygenation (Oxyhemoglobin and Deoxyhemoglobin) is measured by noncontact hyperspectral imaging (HSI) camera. Only the right foot was analyzed and without footwear. The accepted measure of oxyhemoglobin and deoxyhemoglobin is arbitrary units (AU). NIR spectrum light passes through skin and is reflected off the blood supplying the tissue. Wavelength dependent light absorption of hemoglobin differs if it is carrying oxygen or not, therefore detecting oxygenated and deoxygenated blood. This was derived from Beer-Lambert Law but would need to be verified by the manufacturer. There is no researcher drawn calculation as the device provides the arbitrary unit based on the reflectance detected back to the imaging device. No reference values or any standardization available but one would infer higher oxyhemoglobin level indicates better oxygenation and thus a higher deoxyhemoglobin would be indicative of poor oxygenation. | We gathered and assessed measurements of the plantar lateral foot at baseline for both healthy and diabetic participants combined that is reported here. | Posted | Median | Inter-Quartile Range | Arbitrary Units (AU) | Baseline (30 minutes after start of visit 1) |
|
|
|
| Secondary | Tissue Oxygenation (Oxygen Saturation) - for Plantar Medial Foot | Plantar Medial foot tissue oxygenation (Oxygen saturation) is measured by noncontact hyperspectral imaging camera (StO2). Only the right foot was analyzed and without footwear. | We gathered and assessed measurements of the plantar medial foot at baseline for both healthy and diabetic participants combined that is reported here. | Posted | Median | Inter-Quartile Range | percentage StO2 | Baseline (30 minutes after start of visit 1) |
|
|
|
| Secondary | Tissue Oxygenation (Oxyhemoglobin and Deoxyhemoglobin) - for Plantar Medial Foot | Plantar medial foot tissue oxygenation (Oxyhemoglobin and Deoxyhemoglobin) is measured by noncontact hyperspectral imaging (HSI) camera. Only the right foot was analyzed. Only the right foot was analyzed and without footwear. The accepted measure of oxyhemoglobin and deoxyhemoglobin is arbitrary units (AU). NIR spectrum light passes through skin and is reflected off the blood supplying the tissue. Wavelength dependent light absorption of hemoglobin differs if it is carrying oxygen or not, therefore detecting oxygenated and deoxygenated blood. This was derived from Beer-Lambert Law but would need to be verified by the manufacturer. There is no researcher drawn calculation as the device provides the arbitrary unit based on the reflectance detected back to the imaging device. No reference values or any standardization available but one would infer higher oxyhemoglobin level indicates better oxygenation and thus a higher deoxyhemoglobin would be indicative of poor oxygenation. | We gathered and assessed measurements of the plantar medial foot at baseline for both healthy and diabetic participants combined that is reported here. | Posted | Median | Inter-Quartile Range | Arbitrary Units (AU) | Baseline (30 minutes after start of visit 1) |
|
|
|
| Secondary | Tissue Oxygenation (Oxygen Saturation) - for Plantar Lateral Foot | Plantar foot tissue oxygenation (Oxygen saturation) is measured by noncontact hyperspectral imaging camera (StO2). Only the right foot was analyzed and without footwear. | We gathered and assessed measurements of the plantar lateral foot at baseline for both healthy and diabetic participants combined that is reported here. | Posted | Median | Inter-Quartile Range | percentage StO2 | Post Gait (approx. 2015 seconds post intervention) |
|
|
|
| Secondary | Tissue Oxygenation (Oxyhemoglobin and Deoxyhemoglobin ) - for Plantar Lateral Foot | Plantar foot tissue oxygenation (Oxyhemoglobin and Deoxyhemoglobin) is measured by noncontact hyperspectral imaging (HSI) camera. Only the right foot was analyzed and without footwear. The accepted measure of oxyhemoglobin and deoxyhemoglobin is arbitrary units (AU). NIR spectrum light passes through skin and is reflected off the blood supplying the tissue. Wavelength dependent light absorption of hemoglobin differs if it is carrying oxygen or not, therefore detecting oxygenated and deoxygenated blood. This was derived from Beer-Lambert Law but would need to be verified by the manufacturer. There is no researcher drawn calculation as the device provides the arbitrary unit based on the reflectance detected back to the imaging device. No reference values or any standardization available but one would infer higher oxyhemoglobin level indicates better oxygenation and thus a higher deoxyhemoglobin would be indicative of poor oxygenation. | We gathered and assessed measurements of the plantar lateral foot at baseline for both healthy and diabetic participants combined that is reported here. | Posted | Median | Inter-Quartile Range | Arbitrary Units (AU) | Post Gait (approx. 2015 seconds post intervention) |
|
|
|
| Secondary | Tissue Oxygenation (Oxygen Saturation) - for Plantar Medial Foot | Plantar Medial foot tissue oxygenation (Oxygen saturation) is measured by noncontact hyperspectral imaging camera (StO2). Only the right foot was analyzed and without footwear. | We gathered and assessed measurements of the plantar medial foot at baseline for both healthy and diabetic participants combined that is reported here. | Posted | Median | Inter-Quartile Range | percentage StO2 | Post Gait (approx. 2015 seconds post intervention) |
|
|
|
| Secondary | Tissue Oxygenation (Oxyhemoglobin and Deoxyhemoglobin) - for Plantar Medial Foot | Plantar medial foot tissue oxygenation (Oxyhemoglobin and Deoxyhemoglobin) is measured by noncontact hyperspectral imaging (HSI) camera. Only the right foot was analyzed and without footwear. The accepted measure of oxyhemoglobin and deoxyhemoglobin is arbitrary units (AU). NIR spectrum light passes through skin and is reflected off the blood supplying the tissue. Wavelength dependent light absorption of hemoglobin differs if it is carrying oxygen or not, therefore detecting oxygenated and deoxygenated blood. This was derived from Beer-Lambert Law but would need to be verified by the manufacturer. There is no researcher drawn calculation as the device provides the arbitrary unit based on the reflectance detected back to the imaging device. No reference values or any standardization available but one would infer higher oxyhemoglobin level indicates better oxygenation and thus a higher deoxyhemoglobin would be indicative of poor oxygenation. | We gathered and assessed measurements of the plantar medial foot at baseline for both healthy and diabetic participants combined that is reported here. | Posted | Median | Inter-Quartile Range | Arbitrary Units (AU) | Post Gait (approx. 2015 seconds post intervention) |
|
|
|
| Secondary | Balance | Positional sense measured by body-worn sensors (cm) | Data were not able to be collected and were considered invalid due to an equipment malfunction (technical difficulties with the sensors).Therefore, this technical issue prevented an assessment and collection of the data. | Posted | Baseline |
|
|
| 0 |
| 20 |
| 0 |
| 20 |
| 0 |
| 20 |
| EG001 | Patients With Diabetic Neuropathy | Patients with diagnosed diabetes and neuropathy who do not have foot wounds or history of amputation. | 0 | 1 | 0 | 1 | 0 | 1 |
Not provided
Not provided
Not provided
| D007871 |
| Leg Ulcer |
| D012883 | Skin Ulcer |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D048909 | Diabetes Complications |
| D003920 | Diabetes Mellitus |
| D004700 | Endocrine System Diseases |
| D003929 | Diabetic Neuropathies |
| Cell 4 |
|
| Cell 7 |
|
| Cell 4 |
|
| Cell 7 |
|
| Cell 4 |
|
| Cell 7 |
|
| Cell 4 |
|
| Cell 7 |
|
| Cell 4 |
|
| Cell 7 |
|